0001593968-22-000745.txt : 20220314
0001593968-22-000745.hdr.sgml : 20220314
20220314165327
ACCESSION NUMBER: 0001593968-22-000745
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220311
FILED AS OF DATE: 20220314
DATE AS OF CHANGE: 20220314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brockstedt Dirk G.
CENTRAL INDEX KEY: 0001635616
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38997
FILM NUMBER: 22737301
MAIL ADDRESS:
STREET 1: C/O ADURO BIOTECH, INC.
STREET 2: 740 HEINZ AVENUE
CITY: BERKELEY
STATE: CA
ZIP: 94710
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RAPT Therapeutics, Inc.
CENTRAL INDEX KEY: 0001673772
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473313701
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 489-9000
MAIL ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FLX Bio, Inc.
DATE OF NAME CHANGE: 20160504
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2022-03-11
0001673772
RAPT Therapeutics, Inc.
RAPT
0001635616
Brockstedt Dirk G.
C/O RAPT THERAPEUTICS, INC.,
561 ECCLES AVENUE
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
Chief Scientific Officer
Common Stock
2022-03-11
4
M
false
2648
6.18
A
22460
D
Common Stock
2022-03-11
4
S
false
2648
23.91
D
19812
D
Option (right to buy)
6.18
2022-03-11
4
M
false
2648
0
D
2028-03-27
Common Stock
2648
17047
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
/s/ Rodney Young, Attorney-in-Fact for Dirk G Brockstedt
2022-03-14